Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide ra


Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to

Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives.  

 

To order this 250+ page report, which features 100+ figures and 120+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

 

The USD 2.6 billion (by 2030) financial opportunity within the China biopharmaceutical contract manufacturing market has been analyzed across the following segments:

  • Type of Product 
  • API
  • FDF

 

  • Type of Expression System Used
  • Mammalian
  • Microbial
  • Others

 

  • Scale of Operation
  • Preclinical / Clinical
  • Commercial

 

  • Size of Manufacturer
  • Small
  • Mid-sized
  • Large / Very Large

 

  • Type of Biologic 
  • Antibody 
  • Vaccine
  • Others

 

The China Biopharmaceutical Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • ChemPartner Biologics
  • JHL Biotech
  • JOINN Biologics
  • MabPlex
  • Mycenax Biotech
  • WuXi AppTec

 

To request for sample report -  https://www.rootsanalysis.com/reports/313/request-sample.html

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction
  3. Case Study: Comparison of Small Molecules and Large Molecules
  4. Competitive Landscape
  5. Company Profiles
  6. Partnerships
  7. Recent Expansions
  8. Clinical Trial Analysis
  9. Regional Capability Analysis
  10. Capacity Analysis
  11. Big Pharma Biopharmaceutical Manufacturing Initiatives in China
  12. Make Versus Buy Decision Making Framework
  13. Market Sizing and Opportunity Analysis

 

  1. COVID-19 Impact on China Biopharmaceutical CMO Market

 

  1. SWOT Analysis

 

  1. Future of the China Biopharmaceutical CMO Market

 

  1. Interview Transcripts

 

  1. APPENDIX 1: TABULATED DATA

 

  1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis